One small investment offers big benefits for Nvidia.

The agro-based bio-pharmaceuticals and bio-chemicals producer has been plagued by operational and financial delays.

Though the biotech has been dominating this area for a long time, business is still good. In the first quarter, Vertex ...

Emerging growth companies continue to focus on commercialization, manufacturing readiness, artificial intelligence ...

U.S. stocks edged higher in midday trading as SK Hynix rallied in its U.S. trading debut. Fed Names VC Marc Andreessen, Ex-Walmart CEO Doug McMillon to Warsh's Task Forces The external advisers will ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

Biotech is the story at midday Friday, and it’s not a pretty one for shareholders who chased the sector’s monster 2026 run.

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

U.S. stocks rose as fears about a return to full-blown war in Iran subsided. The Chip Trade Is Helping Wall Street Shake Off Latest Iran Strikes Flaring tensions in the Middle East were overshadowed ...

CNBC’s Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter. Instead, he highlighted a group ...

Both stocks are delivering strong returns. Shares of Incyte are up more than 17% this year, while TG Therapeutics is up ...

Michael Yee, UBS biotech analyst, joins 'The Exchange' to discuss Yee's thoughts on biotech stocks, what's driving the ...